Merck & Co. Inc.’s reported positive results Tuesday for a new, easier-to-administer formulation of its blockbuster cancer ...

Alzheimer's disease—the most common form of dementia—is a progressive neurological disorder that causes brain cells to ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

A new study showed that methylated tirilazad treatment resulted in "significant improvement in clinical signs, blood markers, ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

"By repurposing existing drugs, we aim to bypass some of the lengthy and expensive steps in traditional antibiotic discovery, ...

New Bedford police have arrested a Dartmouth man who allegedly fled from police while wearing a GPS monitor and being in ...

The new ulcerative colitis (UC) triumvirate in Johnson & Johnson’s Tremfya, AbbVie’s Skyrizi and Eli Lilly’s Omvoh is rapidly ...

The invention uses light, sound and bubbles to quickly create copies of soft tissue that might one day support testing individualized therapies for cancer and other diseases ...